Overview / Abstract: |
Target Audience This online educational activity is directed toward neurologists, primary care physicians, physician assistants, and nurses specializing in neurologic disorders. Program Overview This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of Alzheimer disease (AD), with a forward-looking perspective on how new and novel agents might impact clinical practice. The epidemiology, pathophysiology, diagnosis, emerging biomarkers, current and emerging treatment strategies, and multidisciplinary approach to AD management will be presented in a multimedia format, including a series of video interviews with expert thought leaders integrated into text-based learning elements. Learning Objectives Upon completion of this activity, you should be better prepared to: Differentiate neurodegenerative changes that are considered the hallmarks of AD compared with other neurodegenerative disorders |
Expiration |
Jul 15, 2021 |
Discipline(s) |
Nursing CNE, Physician CME |
Format |
Online |
Credits / Hours |
1.0 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty Richard S. Isaacson, MD, FAAN Stephen Salloway, MD, MS |
Sponsors / Supporters / Grant Providers |
Biogen and Eisai Inc. |
Keywords / Search Terms |
Relias LLC FREE CME., Relias LLC., Alzheimer Disease Free CE CME |